Anthropic Targets $1.4 Trillion Valuation in Hotly Awaited IPO
Anthropic will list 825 million shares at $70-$78 on the Nasdaq, targeting a $1.4 trillion valuation, with UK platforms opening subscriptions from $250 minimum.
By Olivia Hart
3 min read

What's News
- Anthropic's IPO is expected to value the company at $1.4tn (£1tn), with shares reported to be six times oversubscribed
- 825m class A shares priced between $70 and $78; final price set Wednesday, Nasdaq listing Thursday
- Class A shares carry only 49.9% of total voting power combined
- UK minimum investments range from $250 (£189) at Robinhood and eToro to £1,000 at AJ Bell
- SpaceX shares have traded below their June IPO price at points since listing
Anthropic, the maker of the Claude chatbot, expects its initial public offering to value the company at $1.4 trillion (£1 trillion), with reports suggesting demand could run to six times the shares on offer. The float lands amid a volatile stretch for technology stocks, and the final price will not be set until Wednesday.
The prospectus details the offering: 825 million class A common shares, priced between $70 and $78 each. Retail investors get a seat at the table alongside institutions when the stock lists on the Nasdaq in New York on Thursday. But the share class comes with a structural limit — even if all its votes are combined, they represent only 49.9% of the total vote. Buyers cannot force changes in how the company is run.
How can UK investors buy in?
Several platforms are offering direct subscription, with sharply different entry costs:
- Robinhood and eToro: minimum investment of $250 (£189)
- Hargreaves Lansdown: minimum of £250
- AJ Bell: minimum of £1,000
The deadlines are tight. AJ Bell closes applications at 1pm on Wednesday; Hargreaves Lansdown and Robinhood close at 3pm. All three platforms say they could shut the door early without notice. Once the shares list on Thursday, they can be bought through any platform, including those that skipped the IPO entirely.
There is also a passive route in. Anthropic's stock will eventually enter tracker funds, some faster than others, and active fund managers may buy too. Investors who never touch the IPO could still end up holding Anthropic through their existing portfolios.
Is the deal worth the price?
Jason Hollands, managing director of Bestinvest by Evelyn Partners — a platform not participating in the IPO — urged caution alongside the enthusiasm. "Anthropic would give most retail investors the first opportunity to have a direct stake in a frontier AI developer. But it remains a capital-intensive business, and it has yet to establish a consistent path to profitability," he said. "Investors will need to judge whether the company can turn demand for its models into durable earnings."
Hollands stress-tested the oversubscription narrative directly. If demand exceeds the limited supply, "that could support the price initially with a 'pop', but it does not guarantee a strong debut or lasting gains over the coming months."
He pointed to a recent precedent. The SpaceX listing in June, he said, "is a reminder that a hotly anticipated IPO and early enthusiasm can quickly be followed by volatility: its shares have traded below their IPO price at points since listing." In plain terms: a strong first day tells you nothing about month six.
Notably absent from the prospectus coverage so far: any figure for current revenue or a stated timeline to profit. The valuation rests on demand for frontier AI models, not demonstrated earnings.
What does Claude say?
Asked whether to buy shares, Anthropic's own chatbot declined the role of adviser — and flagged its own bias. "I can't tell you whether you should buy. I'm not a financial adviser, and I'm also made by Anthropic, so I have an obvious conflict of interest here," Claude said.
The chatbot then laid out questions any investor should answer before buying into an IPO: Can you absorb a loss if the share falls? What share of your portfolio would the position represent? Will you already hold exposure through a tracker fund?
That last question deserves weight. An investor buying directly while holding a broad tracker could end up doubling their bet without noticing. For a company that has not proven it can turn demand into profit, sizing the position — and knowing what you already own — may matter more than catching the listing pop.
Source: theguardian.com
More from Olivia Hart
Show full bio
Staff writer covering people, launches and day-to-day practice in entrepreneurship, startups and venture funding at Business Bearings.
2,221 articles